Search
Avelumab
go.drugbank.com/drugs/DB11945ApprovedInvestigational[A261496] On September 18 and December 18 of the same year, it was also granted approval by EMA [L48126] and Health Canada,[L48171] respectively. … [A261496] Avelumab was first approved by the FDA on March 23, 2017.
Categories: Amino Acids, Peptides, and Proteins, Antineoplastic and Immunomodulating AgentsProducts: BAVENCIO CONCENTRATE FOR SOLUTION FOR INFUSION 200MG/10ML, BAVENCIO 200 mg/10mL concentrate for solution for infusionGinkgo biloba
go.drugbank.com/drugs/DB01381ApprovedInvestigationalNutraceutical_Ginkgo biloba_ is found in a number of homeopathic and over-the-counter herbal products and dietary supplements, but it has no approved therapeutic indications by regulatory bodies, such as the FDA, EMA … [A232379] _Ginkgo folium_, the leaf extract of _Ginkgo biloba_, is considered an anti-dementia drug by the World Health Organization.[A232389]
Mixtures: Bee Venom Wart And Tags Removal TreatmentCategories: donepezil, memantine and Ginkgo foliumGabapentin
go.drugbank.com/drugs/DB00996ApprovedInvestigationalIt is structurally and functionally related to another GABA derivative, [pregabalin]. … [A14097,A186179] Gabapentin has some stark advantages as compared with other anti-epileptics, such as a relatively benign adverse effect profile, wide therapeutic index, and lack of appreciable metabolism
Categories: Gabapentin and Prodrugs, Amino Acids, Peptides, and ProteinsProducts: GEMUDA 250MG/5ML ORAL ÇÖZELTI, 470 ML, 1 ŞIŞE, EVEPTIN 250MG/5ML ORAL ÇÖZELTI, 470 ML, 1 ŞIŞENaratriptan
go.drugbank.com/drugs/DB00952ApprovedNaratriptan is a triptan drug that is selective for the 5-hydroxytryptamine1 receptor subtype. It is typically used for the treatment of migraine headaches.
Categories: Serotonin-1b and Serotonin-1d Receptor AgonistProducts: NARATRIPTAN AL 2.5MG, NARATRIPTAN HEXAL 2.5MGCandida albicans
go.drugbank.com/drugs/DB10429ApprovedInvestigationalCandida albicans is a fungus which can provoke allergic reactions. Candida albicans is used in allergenic testing.
Products: Molds, Rusts and Smuts, Candida albicansAngelica archangelica root
go.drugbank.com/drugs/DB14283ApprovedIt is not an approved drug.
Products: Florasun Angelique Cap 250mg, Park no suk a clear walk of parkDroperidol
go.drugbank.com/drugs/DB00450ApprovedInvestigationalVet approvedIt is also used as a premedicant, as an antiemetic, and for the control of agitation in acute psychoses. (From Martindale, The Extra Pharmacopoeia, 29th ed, p593) … It is used in conjunction with an opioid analgesic such as fentanyl to maintain the patient in a calm state of neuroleptanalgesia with indifference to surroundings but still able to cooperate with the
Categories: Miscellaneous Anxiolytics Sedatives and HypnoticsProducts: Inapsine Inj 2.5mg/ml, Droperidol Injection USP 2.5mg/mlTestosterone cypionate
go.drugbank.com/drugs/DB13943ApprovedInvestigationalIt was developed by the company Pharmacia and Upjohn and FDA approved on July 25, 1979. … Testosterone cypionate is a synthetic derivative of testosterone in the form of an oil-soluble 17 (beta)-cyclopentylpropionate ester.
Categories: Testosterone and derivatives, Hormones, Hormone Substitutes, and Hormone AntagonistsProducts: .- Im 100mg/ml, Depo-testosterone Inj 100mg/mlLetermovir
go.drugbank.com/drugs/DB12070ApprovedInvestigational[A31290] Letermovir has recieved both priority and orphan drug status from the FDA. It is currently marketed under the brand name Prevymis.[L1021] … Letermovir recieved approval from the FDA on November 8th, 2017 for use in prophylaxis of cytomegalovirus (CMV) infection in allogeneic hematopoietic stem cell transplant patients.
Products: PREVYMIS CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/ML, PREVYMIS 240mg/12mL (20mg/mL) concentrate for solution for infusionSecukinumab
go.drugbank.com/drugs/DB09029ApprovedInvestigational[A249840] Following its first global approval in Japan in December 2014, secukinumab was approved by the European Commission on January 15, 2015, and by the FDA a few days after (January 21, 2015). … [A249805] It is currently approved to treat a number of chronic inflammatory conditions, such as plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and hidradenitis suppurativa.
Categories: Amino Acids, Peptides, and Proteins, Antineoplastic and Immunomodulating AgentsProducts: COSENTYX SOLUTION FOR INJECTION IN PREFILLED SYRINGE 75MG/0.5ML, Fraizeron 150mg Powder for Solution for Injection